Heron Therapeutics, Inc. (HRTX)

NASDAQ: HRTX · Real-Time Price · USD

0.8481

-0.0113 (-1.31%)

At close: May 19, 2026, 4:00 PM EDT

0.8568

+0.0087 (1.03%)

After-hours: May 19, 2026, 7:02 PM EDT

Heron Therapeutics Employees

Heron Therapeutics had 128 employees as of December 31, 2025. The number of employees increased by 6 or 4.92% compared to the previous year.

Employees

128

Change (1Y)

Growth (1Y)

4.92%

Revenue / Employee

$1,177,438

Profits / Employee

-$241,727

Market Cap

160.53M

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	128	6	4.92%
Dec 31, 2024	122	-4	-3.17%
Dec 31, 2023	126	-77	-37.93%
Dec 31, 2022	203	-99	-32.78%
Dec 31, 2021	302	79	35.43%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
Karyopharm Therapeutics	228
Protalix BioTherapeutics	226
Immunic	92
Tenaya Therapeutics	70
Acumen Pharmaceuticals	61
Corbus Pharmaceuticals Holdings	36
Enlivex	34
Elicio Therapeutics	33